文献速递治疗药物监测与药物基因组学抗菌药物管理

Nephrocast-V:利用电子健康记录数据预测万古霉素谷浓度的深度学习模型

Nephrocast-V: A Deep Learning Model for the Prediction of Vancomycin Trough Concentration Using Electronic Health Record Data.
PubMed 文献 · Pharmacotherapy · 2025-09-30

本研究利用加州大学圣地亚哥分校重症监护病房2016至2024年的电子健康记录数据,训练并验证了一种结合长短期记忆与多头注意力层的深度学习模型,用于提前2天预测万古霉素谷浓度。模型在2205例患者中达到平均绝对误差3.15 mg/L和均方根误差4.17 mg/L,性能与借助贝叶斯给药软件的重症药师相当,且偏离模型推荐剂量通常与未达治疗水平相关。

要点

  • 深度学习模型可提前2天预测重症患者万古霉素谷浓度。
  • 模型误差MAE 3.15 mg/L、RMSE 4.17 mg/L,与药师辅助软件相当。
  • 偏离模型剂量推荐与未达治疗水平谷浓度相关。

核心结论

  • 深度学习可用于重症患者万古霉素治疗药物监测的个体化支持。

研究设计与样本

  • 研究为模型训练与验证,使用2016年1月1日至2024年6月30日加州大学圣地亚哥分校重症监护病房成人电子健康记录数据,共纳入2205例符合条件患者。
  • 模型架构结合长短期记忆层和多头注意力层,并通过跳跃连接在最终层纳入既往剂量信息。
  • 模型性能以平均绝对误差和均方根误差评估。

主要发现

  • 模型预测万古霉素谷浓度的平均绝对误差为3.15 mg/L,均方根误差为4.17 mg/L。
  • 模型性能与借助贝叶斯给药软件的重症药师相当。
  • 偏离患者特异性模型剂量推荐通常与未达治疗水平的万古霉素浓度相关。

临床怎么用

  • 可考虑将深度学习模型作为重症患者万古霉素治疗药物监测的辅助工具,提前2天预测谷浓度并参考剂量调整建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Vancomycin is a critical antibiotic for treating methicillin-resistant Staphylococcus aureus and other gram-positive bacterial infections, but achieving and maintaining therapeutic trough concentrations is challenging. OBJECTIVES: We hypothesized that a deep learning model could accurately predict vancomycin trough concentrations 2 days in advance in critically ill patients and provide recommendations for optimal dosing adjustments to achieve target drug concentrations. METHODS: We trained and validated the model using electronic health record (EHR) data from adults admitted to the University of California San Diego Health system intensive care units (ICUs) from January 1, 2016, to June 30, 2024. Features included patient demographics, comorbidities, vital signs, laboratory measurements, medications, and vancomycin dosing information. The model architecture combined Long Short-Term Memory and Multi-Head Attention layers, supplemented with skip connections to incorporate past dosage information at the final layer of the deep learning model. Model performance was evaluated using mean absolute error (MAE) and root mean square error (RMSE) metrics. RESULTS: A total of 2205 encounters met the eligibility criteria. The median age was 57 years, and the median ICU length of stay was 4.9 days. The model achieved an MAE of 3.15 mg/L and an RMSE of 4.17 mg/L, comparable to that of a critical care pharmacist aided by a Bayesian dosing software. Additionally, deviations from patient-specific model-based dose recommendations were generally associated with nontherapeutic vancomycin levels. CONCLUSION: This study demonstrates the potential to leverage deep learning to individualize and support vancomycin therapeutic drug monitoring in critically ill patients.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Ghanbari G, Stevens C, Aronoff-Spencer E, et al. Nephrocast-V: A Deep Learning Model for the Prediction of Vancomycin Trough Concentration Using Electronic Health Record Data. Pharmacotherapy. 2025. PMID: 41025800. doi:10.1002/phar.70062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。